Efficacy and Safety of Novosis Putty for Degenerative Lumbar Disease

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2025

Conditions

Degenerative Lumbar Diseases

Interventions

DEVICE

Bone graft materials and rhBMP-2

NOVOSIS PUTTY is a product composed of recombinant human bone morphogenetic protein-2 and β-tricalcium phosphate/hydrogel complex.

Trial Locations (1)

Severance hospital, Seoul

All Listed Sponsors

lead

CGBio Inc.

INDUSTRY